Brachial plexopathy as a complication of COVID-19

BMJ Case Rep. 2021 Mar 25;14(3):e237459. doi: 10.1136/bcr-2020-237459.

Abstract

COVID-19 affects a wide spectrum of organ systems. We report a 52-year-old man with hypertension and newly diagnosed diabetes mellitus who presented with hypoxic respiratory failure due to COVID-19 and developed severe brachial plexopathy. He was not treated with prone positioning respiratory therapy. Associated with the flaccid, painfully numb left upper extremity was a livedoid, purpuric rash on his left hand and forearm consistent with COVID-19-induced microangiopathy. Neuroimaging and electrophysiological data were consistent with near diffuse left brachial plexitis with selective sparing of axillary, suprascapular and pectoral fascicles. Given his microangiopathic rash, elevated D-dimers and paucifascicular plexopathy, we postulate a patchy microvascular thrombotic plexopathy. Providers should be aware of this significant and potentially under-recognised neurologic complication of COVID-19.

Keywords: infections; neurological injury; neuromuscular disease; pain (neurology); peripheral nerve disease.

Publication types

  • Case Reports

MeSH terms

  • Arm / pathology
  • Brachial Plexus Neuropathies / diagnosis
  • Brachial Plexus Neuropathies / etiology*
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • Diabetes Mellitus
  • Exanthema / complications
  • Fibrin Fibrinogen Degradation Products / analysis
  • Humans
  • Hypertension / complications
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuralgia / complications
  • Patient Positioning / adverse effects
  • Respiratory Insufficiency / etiology
  • SARS-CoV-2 / isolation & purification

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D